Mesa Labs Q3 revenue up 60% to $54.7M; GAAP operating loss $2.5M on Agena acquisition costs

MESA LABORATORIES INC /CO/

2022-Q3 EPS reported $0.69 revenue$125,456,000

Q3 revenue $54.7M (+60% YoY); organic revenue growth 12%.
GAAP operating loss $2.5M; net loss $0.39/diluted share.
Non-GAAP adjusted op. income $7.1M; excl. unusual items $13.8M (+73%).
Biopharma division organic growth 46%; Calibration Solutions revenue fell 6%.
Acquired Agena Bioscience in Oct 2021; cash reserves fell from $264M to $52M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.